Evidence map›Paper›PMID 42063713›Full record

ReviewFrontiers in oncology2026

QUAD SHOT radiotherapy for palliation in advanced cancer: current status and future directions.

Xia Liu, Zheng-Yun Du, Zhao-Feng Ning, Jian-Liang Liu, Yun-Long Hu, De-Bo Huang

Abstract readReview
In one paragraph

Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xia LiuDepartment of Radiation Oncology, Tai'an Cancer Hospital, Tai'an, Shandong, China.
Zheng-Yun DuDepartment of Radiation Oncology, Tai'an Cancer Hospital, Tai'an, Shandong, China.
Zhao-Feng NingDepartment of Radiation Oncology, Tai'an Cancer Hospital, Tai'an, Shandong, China.
Jian-Liang LiuDepartment of Radiation Oncology, Tai'an Cancer Hospital, Tai'an, Shandong, China.
Yun-Long HuDepartment of Radiation Oncology, Tai'an Cancer Hospital, Tai'an, Shandong, China.
De-Bo HuangDepartment of Radiation Oncology, Tai'an Cancer Hospital, Tai'an, Shandong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

QUAD SHOT radiotherapy (QS-RT) is a periodic, short-course, hypo-fractionated radiotherapy regimen that originated in the 1980s. It is widely used in Europe and the United States, but less so in Asia. Many clinical studies have shown that QS-RT offers significant advantages in improving quality of life and local control and has a favorable safety profile. This article systematically reviews the origin, biological mechanisms, clinical applications, efficacy, and safety of QS-RT based on existing clinical studies, discusses its clinical advantages and limitations, and considers how to optimize future treatment plans.

Indexed as

accelerated radiotherapyhypo-fractionationpalliative treatmentradiotherapysymptom control

Identifiers

PMID42063713
PMCPMC13124485

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.